Mathias Schmid
Papers
1
Total Citations
32
H-Index
1
About
No biography available yet.
Research Focus
Bladder cancer1 · 32 citations
Cancer1 · 32 citations
Chemoimmunotherapy1 · 32 citations
Chemotherapy1 · 32 citations
Cisplatin1 · 32 citations
Clinical endpoint1 · 32 citations
Clinical trial1 · 32 citations
Durvalumab1 · 32 citations
Gemcitabine1 · 32 citations
Immunotherapy1 · 32 citations
Interim analysis1 · 32 citations
Internal medicine1 · 32 citations
Key Achievements
1
H-Index
1
Papers
32
Total Citations
32
Avg Citations/Paper
🏆 Most Cited Paper
Perioperative chemoimmunotherapy with durvalumab (Durva) in combination with cisplatin/gemcitabine (Cis/Gem) for operable muscle-invasive urothelial carcinoma (MIUC): Preplanned interim analysis of a single-arm phase II trial (SAKK 06/17).
32 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Triemli Hospital
Top Papers
- 1
Key Collaborators
MSMartin Spahn1 shared papersSAStefanie Aeppli1 shared papersNMNicolas Mach1 shared papersMSMartina Schneider1 shared papersDZDeborah Zihler1 shared papersDBDominik Berthold1 shared papersJSJulian Schardt1 shared papersAEAndreas Erdmann1 shared papersRTRaeto T. Strebel1 shared papersRSRoland Seiler1 shared papersMPMiklos Pless1 shared papersBHBoris Hadaschik1 shared papersSISacha I. Rothschild1 shared papersCBChristine Biaggi Rudolf1 shared papersSHStefanie Hayoz1 shared papersRCRichard Cathomas1 shared papersUPUlf Petrausch1 shared papers
Not generated yet